Researchers continue to excited about the medication , a innovative dual agonist showing remarkable outcomes in clinical trials for weight reduction . It functions by targeting two hormones : GLP-1 and GIP, https://hannaadiw358931.targetblogs.com/41087565/a-new-prospect-for-weight-management